San Francisco, CANCT07214545Now EnrollingIRB Ready

Attention Deficit Disorder With Hyperactivity (ADHD) Clinical Trial in San Francisco, CA

Access cutting-edge attention deficit disorder with hyperactivity (adhd) treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Francisco

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access attention deficit disorder with hyperactivity (adhd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related attention deficit disorder with hyperactivity (adhd) treatment provided free

Apply for This San Francisco Location

Check if you qualify for this attention deficit disorder with hyperactivity (adhd) clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Attention Deficit Disorder With Hyperactivity (ADHD) Study in San Francisco

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Sponsor: University of California, San Francisco

Who Can Participate

Inclusion Criteria

Confirmed clinician diagnosis of ASD according to DSM-5 criteria, corroborated by prior testing (or obtained in study screening) with the Autism Diagnostic Observation Schedule (ADOS) with or without the Autism Diagnostic Interview-Revised (ADI-R)
IQ \> 70 as corroborated by prior testing (or obtained in study screening) with the Wechsler Abbreviated Scale of Intelligence Scale (WASI)
Confirmed diagnosis of ADHD according to DSM-5 criteria with minimum ADHD-RS score of \> 24
Stable on current medications for a minimum of 4 weeks before baseline
Ability to complete protocol testing
Both the child participant and their primary caregiver must be fluent in English (speaking, reading, and understanding), as the questionnaires and assessment tools used in this study have been validated only in English.

Exclusion Criteria

Current major depression, history of psychosis, bipolar disorder, elevated risk of self-harm
History of moderate to severe coarse brain injury
Active medical illness expected to interfere with study assessments
Presence of implanted stimulator (e.g., vagal nerve stimulator)
Active dermatologic condition likely to interfere with eTNS electrode wearability
Sleep disorder likely to interfere with nightly eTNS in the opinion of the study physician
Inability to communicate discomfort or pain
Current and anticipated continued use of antipsychotic or stimulant medication

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07214545) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Attention Deficit Disorder With Hyperactivity (ADHD) Treatment Options in San Francisco, CA

If you're searching for attention deficit disorder with hyperactivity (adhd) treatment options in San Francisco, CA, this clinical trial (NCT07214545) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced attention deficit disorder with hyperactivity (adhd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all attention deficit disorder with hyperactivity (adhd) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in San Francisco, CA

See all pulmonary embolism clinical trials recruiting in San Francisco — not just this study.

Browse Pulmonary Embolism Trials in San Francisco →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA